COMPANY PROFILE

Implicity

Explore full profile

AI remote monitoring platform for cardiac implant patients

Paris, FranceFounded 2016Health Tech & Medtech

Valuation $50–100M Last recorded · 2022

Revenue $10–50M Latest reported FY

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Implicity

Implicity is a Paris and Cambridge (MA) healthtech company providing AI-driven remote monitoring for patients with pacemakers and implantable defibrillators. Founded in 2016 by cardiac electrophysiologist Arnaud Rosier, the platform aggregates data from multiple device makers and hospital records, with Signal HF predicting hospitalisation risk (FDA-cleared) and productivity AI reducing false alarms using clinical context; company-cited outcomes include about 26% lower mortality. After a $23 million Series A in 2022 (Crédit Mutuel Innovation / Bpifrance and others), Implicity raised €35 million growth funding in September 2026 led by IRIS and Five Arrows (Rothschild & Co) to expand commercially in the US and Germany and pursue tuck-in acquisitions, bringing total capital raised to roughly $69 million. Sources: Tech Funding News / EU-Startups 9 Sep 2026; Implicity.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Paris, France
Employees: 124
Open positions: 6
Dealroom signal: 92.8/100
Industry: Health
Sub-industry: Medical Devices, Health Platform
Sector: Health Tech & Medtech, Cardiology and cardiovascular, Remote Monitoring, Health Information, Patient Care, Telemedicine, Medical Data Systems, Core AI, Medical Data
Technology: Artificial Intelligence
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANT✓Other financing	Mar 2024	$2.5M	—	European Innovation Council	—
SERIES A✓Equity / VC	Apr 2022	$23M	$92M	XAnge · Crédit Mutuel Equity · Karista · Serena	↗

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Implicity website traffic

Latest recorded traffic for Implicity is 28K monthly website visits, down 17.6% over the last three months. Implicity's team grew 30.5% over the past year.

Latest monthly visits28K 3-month web change-17.6% 1-year team growth+30.5%

Monthly website visitsFeb 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Patient Engagement SpecialistCSM & Support · Sep 4, 2026 Logistics ManagerLogistics · Aug 26, 2026 Backend Engineer - Data PlatformBackend Development · Aug 25, 2026 Senior Data EngineerData Science & Engineering · Aug 21, 2026 Deep Learning EngineerData Science & Engineering · Aug 1, 2026 Software / Backend Engineer ApprenticeBackend Development · Aug 1, 2026

6 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CICIBILTECHProvides a prediction of kidney allograft survival, enabling clinicians to anticipate patient health outcomes, improving medical decisions through personalized treatments	Paris, France	Operational	34	$2.5M	$20M
PIPixylNeuroimaging AI for Improved Patient Care	La Tronche, France	Acquired
INinHEARTAI-enabled digital twin of the heart	Pessac, France	Operational
VBVital BeatsVital Beats software platform delivers AI-powered diagnostics and remote follow-up for patients with cardiac devices and wearables	Copenhagen, Denmark	Operational
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
POPososDeveloping artificial intelligence-based solutions, capable of immediately answering questions about medications	Paris, France	Operational
MOmoveUPAI-powered digital therapy for remote patient monitoring	City of Brussels, Belgium	Operational
PRPrimaaDeveloping AI-based software for histological diagnoses, improving a vital step in the detection of cancer	Paris, France	Operational